CompletedNCT02442479
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults
Phase not reported · 127 planned enrolment
- Countries listed
- 1
- Registry update
- April 25, 2016
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
4,444 matching trial registrations
Showing 3,871–3,900 of 4,444. Every record below meets all the filters shown above.
CompletedNCT00967213
Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
PHASE3 · 10 planned enrolment
- Countries listed
- 1
- Registry update
- April 22, 2016
UnknownNCT02749149
Does Frailty Help Predict Postoperative Outcomes in Cardiac Surgery?
Phase not reported · 120 planned enrolment
- Countries listed
- 0
- Registry update
- April 22, 2016
CompletedNCT01408654
Social Connections and Healthy Aging (The Senior Connection)
PHASE2 · 368 planned enrolment
- Countries listed
- 1
- Registry update
- April 22, 2016
TerminatedNCT00413933
Comprehensive Intervention for Falls Prevention in the Elderly
Phase not reported · 8 planned enrolment
- Countries listed
- 0
- Registry update
- April 21, 2016
CompletedNCT02745314
Frailty and Mortality in Older Old With Severe Aortic Stenosis
Phase not reported · 605 planned enrolment
- Countries listed
- 1
- Registry update
- April 20, 2016
CompletedNCT01527435
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Phase not reported · 200 planned enrolment
- Countries listed
- 1
- Registry update
- April 6, 2016
UnknownNCT02317757
Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients
Phase not reported · 150 planned enrolment
- Countries listed
- 1
- Registry update
- April 4, 2016
CompletedNCT01573728
Role of Exercise in Depression in Middle Aged and Older Adults
Phase not reported · 20 planned enrolment
- Countries listed
- 1
- Registry update
- April 1, 2016
CompletedNCT02076919
First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration
PHASE1 · 110 planned enrolment
- Countries listed
- 0
- Registry update
- April 1, 2016
CompletedNCT02724332
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
PHASE1 · 300 planned enrolment
- Countries listed
- 0
- Registry update
- March 31, 2016
WithdrawnNCT02036723
Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
PHASE3 · 0 planned enrolment
- Countries listed
- 2
- Registry update
- March 31, 2016
WithdrawnNCT02450981
Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration
PHASE1 · 0 planned enrolment
- Countries listed
- 0
- Registry update
- March 31, 2016
TerminatedNCT01189019
HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration
PHASE2 · 40 planned enrolment
- Countries listed
- 1
- Registry update
- March 29, 2016
CompletedNCT01835015
Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration
PHASE1 · 50 planned enrolment
- Countries listed
- 0
- Registry update
- March 25, 2016
CompletedNCT01303484
The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People
EARLY_PHASE1 · 40 planned enrolment
- Countries listed
- 1
- Registry update
- March 25, 2016
CompletedNCT01849692
ESBA1008 Microvolume Study
PHASE2 · 107 planned enrolment
- Countries listed
- 0
- Registry update
- March 24, 2016
UnknownNCT02375581
Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
PHASE2 · 130 planned enrolment
- Countries listed
- 1
- Registry update
- March 22, 2016
CompletedNCT00220805
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration
PHASE2 · 96 planned enrolment
- Countries listed
- 1
- Registry update
- March 21, 2016
CompletedNCT01363570
Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Phase not reported · 70 planned enrolment
- Countries listed
- 1
- Registry update
- March 17, 2016
TerminatedNCT01577381
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
PHASE2 · 10 planned enrolment
- Countries listed
- 1
- Registry update
- March 16, 2016
CompletedNCT00976456
Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer
PHASE3 · 271 planned enrolment
- Countries listed
- 1
- Registry update
- March 10, 2016
TerminatedNCT00423189
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
PHASE4 · 7 planned enrolment
- Countries listed
- 1
- Registry update
- March 4, 2016
CompletedNCT00504959
Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
PHASE4 · 234 planned enrolment
- Countries listed
- 10
- Registry update
- March 4, 2016
CompletedNCT01926977
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration
PHASE1 · PHASE2 · 100 planned enrolment
- Countries listed
- 1
- Registry update
- March 3, 2016
UnknownNCT02325089
ORal ApplianCes for sLeep Apnea of the Elderly
PHASE4 · 500 planned enrolment
- Countries listed
- 0
- Registry update
- March 3, 2016
UnknownNCT01844154
Fracture and Fall Prevention in Elderly With Osteoporosis
Phase not reported · 120 planned enrolment
- Countries listed
- 0
- Registry update
- March 3, 2016
CompletedNCT01032109
Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration
Phase not reported · 45 planned enrolment
- Countries listed
- 1
- Registry update
- February 26, 2016
CompletedNCT01129115
Dose Response Study of Aerobic Exercise in Older Adults
EARLY_PHASE1 · 101 planned enrolment
- Countries listed
- 1
- Registry update
- February 15, 2016
CompletedNCT01796964
Efficacy and Safety Study of ESBA1008 Versus EYLEA®
PHASE2 · 173 planned enrolment
- Countries listed
- 0
- Registry update
- February 9, 2016